These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22986874)

  • 21. [Therapy of alopecia areata with diphenylcyclopropenone].
    Kietzmann H; Hardung H; Christophers E
    Hautarzt; 1985 Jun; 36(6):331-5. PubMed ID: 3160683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hazards in the use of diphencyprone.
    Fernández-Redondo V; Gómez-Centeno P; Flórez A; Toribio J
    Allergy; 2000 Feb; 55(2):202-3. PubMed ID: 10726744
    [No Abstract]   [Full Text] [Related]  

  • 23. Induction of hair growth in alopecia totalis with diphencyprone sensitization.
    Monk B
    Clin Exp Dermatol; 1989 Mar; 14(2):154-7. PubMed ID: 2598490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Five-year experience in the treatment of alopecia areata with DPC.
    El-Zawahry BM; Bassiouny DA; Khella A; Zaki NS
    J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):264-9. PubMed ID: 19744175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diphencyprone and topical tacrolimus as two topical immunotherapeutic modalities. Are they effective in the treatment of alopecia areata among Egyptian patients? A study using CD4, CD8 and MHC II as markers.
    Hunter N; Shaker O; Marei N
    J Dermatolog Treat; 2011 Feb; 22(1):2-10. PubMed ID: 20524872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of alopecia areata with topical sensitizers.
    Sutherland L; Laschinger M; Syed ZU; Gaspari A
    Dermatitis; 2015; 26(1):26-31. PubMed ID: 25581667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of alopecia areata with diphencyprone].
    Suditu G; Toma A; Voiculescu M
    Rev Med Chir Soc Med Nat Iasi; 2001; 105(4):760-2. PubMed ID: 12092234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical efficacy of diphenylcyclopropenone in alopecia areata: retrospective data analysis of 50 patients.
    Chiang K; Atanaskova Mesinkovska N; Amoretti A; Piliang MP; Kyei A; Bergfeld WF
    J Am Acad Dermatol; 2014 Sep; 71(3):595-7. PubMed ID: 25128116
    [No Abstract]   [Full Text] [Related]  

  • 29. Chinese experience in the treatment of alopecia areata with diphenylcyclopropenone.
    Pan R; Liu J; Xuan X; Li B
    J Dermatol; 2015 Feb; 42(2):220-1. PubMed ID: 25545114
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of alopecia areata with diphenylcyclopropenone.
    Kietzmann H; Hardung H
    Acta Derm Venereol; 1985; 65(3):274-5. PubMed ID: 2411093
    [No Abstract]   [Full Text] [Related]  

  • 31. Home-based contact immunotherapy with diphenylcyclopropenone for alopecia areata is as effective and safe as clinic-based treatment in patients with stable disease: A retrospective study of 40 patients.
    Lee S; Lee WS
    J Am Acad Dermatol; 2018 Mar; 78(3):599-601.e1. PubMed ID: 28947296
    [No Abstract]   [Full Text] [Related]  

  • 32. [Squaric acid dibutyl ester and diphencyprone in the therapy of alopecia areata].
    Tosti A; Caponeri GM; Primativo R; Melino M; Veronesi S
    G Ital Dermatol Venereol; 1985; 120(5):371-3. PubMed ID: 4077112
    [No Abstract]   [Full Text] [Related]  

  • 33. Efficacy and safety of diphenylcyclopropenone among Chinese patients with steroid resistant and extensive alopecia areata.
    Luk NM; Chiu LS; Lee KC; Chau CT; Lee VW; Chang M; Lam YK; Lee HC
    J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):e400-5. PubMed ID: 23057682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fexofenadine hydrochloride enhances the efficacy of contact immunotherapy for extensive alopecia areata: Retrospective analysis of 121 cases.
    Inui S; Nakajima T; Toda N; Itami S
    J Dermatol; 2009 Jun; 36(6):323-7. PubMed ID: 19500180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of topical diphenylcyclopropenone for the treatment of extensive alopecia areata.
    Cotellessa C; Peris K; Caracciolo E; Mordenti C; Chimenti S
    J Am Acad Dermatol; 2001 Jan; 44(1):73-6. PubMed ID: 11148480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical immunotherapy with diphenylcyclopropenone in the treatment of chronic extensive alopecia areata.
    Sotiriadis D; Patsatsi A; Lazaridou E; Kastanis A; Vakirlis E; Chrysomallis F
    Clin Exp Dermatol; 2007 Jan; 32(1):48-51. PubMed ID: 17004987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recall dermatitis at patch test sites in alopecia areata treated with diphencyprone.
    Nuara A; Cruz PD
    Dermatitis; 2012; 23(2):98-9. PubMed ID: 22653133
    [No Abstract]   [Full Text] [Related]  

  • 38. Alopecia areata: topical immunotherapy treatment with diphencyprone.
    Avgerinou G; Gregoriou S; Rigopoulos D; Stratigos A; Kalogeromitros D; Katsambas A
    J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):320-3. PubMed ID: 18005118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in distribution pattern of CD8 lymphocytes in the scalp in alopecia areata during treatment with diphencyprone.
    Wasyłyszyn T; Kozłowski W; Zabielski SL
    Arch Dermatol Res; 2007 Aug; 299(5-6):231-7. PubMed ID: 17530266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Alopecia areata; pathogenesis and topical immunotherapy].
    Perret CM; Steijlen PM; Happle R
    Ned Tijdschr Geneeskd; 1989 Jun; 133(25):1256-60. PubMed ID: 2666865
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.